MARLBOROUGH, Mass. and NEW ORLEANS, March 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary ...
Watchman isn’t hitting the mark for Boston Scientific. Weak demand for the Left Atrial Appendage (LAA) Closure Device, which was once a jewel in the Marlborough, MA-based company’s crown, sent shares ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results